Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil.
Experimental studies indicate that anastomotic healing in the intestine is compromised by the immediate postoperative administration of 5-fluorouracil and levamisole. Since fibroblast functions are crucial to healing, we investigated the effects of (combinations of) both drugs on proliferation and collagen synthesis of rat skin fibroblasts in vitro. Proliferation was measured in actively dividing cells by cellular [3H]thymidine uptake and collagen synthesis in non-dividing cells by [3H]proline incorporation into collagenase-digestible protein. 5-Fluorouracil strongly and significantly (P < 0.05) reduced DNA synthesis and collagen synthesis at concentrations of 1 microM or more. The latter effect was not specific for collagen since total protein production was affected similarly. Both effects depended on the duration of exposure to the drugs. Levamisole also inhibited fibroblast proliferation dose-dependently, but less effectively than 5-fluorouracil: 50% inhibition was observed at approximately 0.1 mM. Collagen synthesis was unaffected by levamisole. If levamisole was added together with a low (0.1 microM) concentration of 5-fluorouracil, which in itself did not decrease thymidine incorporation, levamisole's antiproliferative effects became apparent at concentrations as low as 1 microM. A similar effect, but at a much higher concentration (1 mM) was noted on fibroblast collagen synthesis. These results indicate that levamisole potentiates 5-fluorouracil effects in fibroblast cultures and that direct effects of these drugs, alone or in combination, on fibroblast proliferation and collagen synthesis may be responsible for their negative influence on wound repair.
de Waard
J W
JW
Department of Surgery, University Hospital Nijmegen, The Netherlands.
de Man
B M
BM
Wobbes
T
T
van der Linden
C J
CJ
Hendriks
T
T
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000714:Anastomosis, Surgical; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002455:Cell Division; D003094:Collagen / Q000096:biosynthesis / Q000187:drug effects*; D004338:Drug Combinations; D004357:Drug Synergism; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D005472:Fluorouracil / Q000494:pharmacology*; D007978:Levamisole / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014945:Wound Healing
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D004338:Drug Combinations; D007978:Levamisole; D003094:Collagen; D005472:Fluorouracil